Please use this product under the supervision of a trained practitioner
MUTAFLOR® IS A PROBIOTIC THAT COMPRISES AS ITS ACTIVE SUBSTANCE A VIABLE NON-PATHOGENIC STRAIN OF ESCHERICHIA COLI (E.COLI). FIRST ISOLATED IN 1917 BY PROFESSOR ALFRED NISSLE FROM THE FAECES OF A SOLDIER DURING THE FIRST WORLD WAR WHO AS HE REMARKED, “IN CONTRAST TO THE LARGE MAJORITY OF HIS COMRADES, HAD SUFFERED NEITHER FROM DYSENTERY NOR FROM ANY OTHER INTESTINAL DISEASES”. THEREAFTER, APPROPRIATELY NAMED ESCHERICHIA COLI STRAIN NISSLE 1917.
Each capsule contains not less than 250 million CFU Escherichia coli strain Nissle 1917
Mutaflor® is registered in Australia at AUST R level for the relief and management of chronic constipation. Your healthcare practitioner may also wish to utilise this strain for its pharmacological and metabolic properties.
Characteristics of Escherichia coli strain Nissle 1917
the ability to colonize
antagonistic activity – Inhibition of growth and or killing of pathogens
anti-invasive – prevention of colonisation in the gut by pathogens
synthesis of endogenous antimicrobial peptides-defensins
mucosal integrity – contributing to luminal metabolism and stability of intestinal milieu-enhanced epithelial barrier function
anti-inflammatory and immunomodulatory effects
stimulation of colonic mucosa
The therapeutic effects of Mutaflor® are strain-specific and have been demonstrated by in-vitro and in-vivo experiments and clinical studies. Mutaflor® Escherichia coli strain Nissle 1917 (EcN) is arguably one of the best-studied and field-tested probiotic strains and fulfils all the demanding criteria and characteristics required for a medicinal probiotic.
Shipping and Storage
Shipping via ambient is perfectly fine. We only ship express and include an icepack to maintain the quality of the product. Please store the product refrigerated as soon as you receive. PLEASE NOTE WE ONLY SHIP THIS ITEM MONDAY AND TUESDAYS